- Abbott
- Abbott Laboratories
- Abcodia
- Accium BioSciences
- Activiomics
- acute kidney injury
- acute myeloid leukemia
- Adaptive Biotechnologies
- addiction
- adenocarcinoma
- Adenocarcinomas
- ADHD
- adrenal cancer
- adrenomedullin
- Advanced Biomarker Technologies
- Advanced Cell Diagnostics
- age-related macular degeneration
- albumin
- alcohol abuse
- allergies
- Alzheimer's
- Alzheimer's disease
- Alzheimer's Disease Neuroimaging Initiative
- American Association for Cancer Reseach
- Amgen
- amyloid beta
- amyotrophic lateral sclerosis
- anemia
- angina
- animal testing
- Anti-depression
- antibodies
- antioxidants
- Aria Diagnostics
- ARISk
- Arsenic
- arthritis
- assays
- asthma
- AstraZeneca
- Asuragen
- atherosclerosis
- athletes
- autism
- autoimmune disease
- autoimmune diseases
- Avantra
- Avastin
- Avid Radiopharmaceuticals
- babies
- Bak
- BAL27862
- Banyan Biomarkers
- Barrett's Esophagus
- Basiliea
- Battelle
- Bayer
- beta-secretase
- BG Medicine
- BGI
- bilirubin
- Biodesix
- Biogen Idec
- biomarker
- biomarker deals
- biomarker detection
- biomarker discovery
- Biomarker growth
- biomarker industry
- Biomarker R&D
- biomarker test
- biomarker validation
- biomarker venture capital
- Biomarkers
- Biomarkers Consortium
- Biosensors
- biosignature
- bipolar disorder
- birth risk
- bladder biomarker
- bladder cancer
- bladder cancer biomarkers
- blood biomarkers
- blood test
- blood tests
- bone fractures
- bortezomib
- Boston Children's Hospital
- Boston Scientific
- bowel cancer
- Brain injuries
- Brain Resource
- brain signals
- brain tumor biomarker
- BRCA1
- BRCA2
- breast cancer
- Breast cancer biomarker
- breath test
- Bristol-Myers Squibb
- CAHM
- Caliper Life Sciences
- cancer
- cancer biomarker
- cancer biomarkers
- cancer diagnostics
- Cancer Genetics
- Cancer Genome Atlas
- cancer immunotherapy
- Cancer Prevention Research
- Cancer Research UK
- cancer stem cell biomarker
- cancer stem cells
- cancer vaccines
- cardiac injury
- Cardiovascular Disease
- cART
- CD1D
- CD4 cells
- Cellular Dynamics International
- Cenix Bioscience
- cerebrospinal fluid
- Ceres Nanosciences
- CFU-Hill cells
- chemotherapy
- chemtherapy
- China
- Christoph Westphal
- Chron's disease
- chronic fatigue syndrome
- chronic kidney disease
- Chronic lymphocytic leukemia
- chronic pain
- Cincinnati Children's Hospital Medical Center
- circulating tumor cells
- cirrhosis
- cisplatin
- Cleveland Clinic
- clinical trial
- clinical trials
- cognitive behavorial therapy
- colon cancer
- colorectal cancer
- companion diagnostic
- companion diagnostics
- concussions
- Congress
- contaminated water
- COPD
- Copeptin
- Coronary artery disease
- Courtagen Life Science
- COX-2
- Creighton University
- Crescendo Bioscience
- Creutzfeldt-Jakob disease
- Critical Diagnostics
- Crohn's disease
- CRP
- CT imaging
- Cyclin D1
- CYP2C9
- Dana-Farber Cancer Institute
- data management
- DCLK1
- Debiopharm
- deep vein thrombosis
- dementia
- depression
- Diabetes
- Diabetes biomarker
- DiaGenic
- diagnostic
- diagnostics
- Digestive Diseases
- DNA
- DNA methylation
- Down syndrome
- drug abuse
- drug development
- Drug discovery
- drug targets
- Dutch Center for Personalized Cancer Treatment
- dyskinesia
- early diagnosis
- Early Stage Breast Cancer
- ECLIPSE
- ectopic pregnancy
- Edwards' Syndrome
- Eli Lilly
- Emory University
- Emory University School of Medicine
- Endocyte
- EPCs
- epigenetic biomarkers
- epigenetics
- epilepsy
- Erbitux
- ERCC1
- Eric Topol
- esophageal adenocarcinoma
- esophageal cancer
- esophagitis
- esophagogastric cancer
- estrogen
- Europe
- Exiqon
- Exonhit Therapeutics
- Ezose Sciences
- FDA
- Febit
- fetal alcohol syndrome
- FGF23
- fibomatosis
- flutemetamol
- fMRI
- Fred Hutchinson Cancer Research Center
- Fujirebio Diagnostics
- gas
- gastroesophageal cancer
- gastrointestinal bacteria
- GE Healthcare
- GeneNews Limited
- Genentech
- genes
- genetic data
- genetic markers
- genetic sequencing
- Genomic Health
- Genomic sequencing
- genomics
- Genomind
- GenWay Biotech
- Gestational diabetes
- GI-4000
- Gilead Sciences
- Glenn Miller
- Glioblastoma
- GlobeImmune
- GnuBio
- GPCRs
- graft-versus-host disease
- GVK Biosciences
- GWAS
- gynecology
- H-FABP
- hair
- head and neck cancer
- HealthLinx
- heart attack
- heart disease
- heart disease biomarkers
- heart failure
- heart stress biomarker
- heart surgery
- HeartLab
- hepatitis B
- hepatitis c
- Hepatits C
- high blood pressure
- HistoRx
- HIV
- HLA molecules
- Hull University
- human-growth hormone
- Hunner lesions
- Huntington's
- Icon
- Ignyta
- IL-6
- IMAGEN
- imaging biomarkers
- immunoassay panel
- immunology
- implantable cardioverter defibrillator
- Indiana University School of Medicine
- infants
- inflammation
- infliximab
- INSERM
- Institute Of Cancer Research
- insulin
- IntegraGen
- Intermountain Medical Center
- interstitial cystitis
- JAMA Psychiatry
- Jan Groen
- Janssen
- Japan
- Jinfiniti Biosciences
- John Radcliffe Hospital
- Johns Hopkins
- Johnson & Johnson
- Journal of Alzheimer's Disease
- Journal of the American College of Cardiology
- Kennedy Institute of Rheumatology
- kidney function
- Kidney Transplant
- King Saud University
- Kyoto University
- LabCorp
- lactate dehydrogenase
- Lead poisoning
- Leiden University Medical Center
- leukemia
- levodopa
- lipid biomarkers
- liquid biopsy
- liver cancer
- liver fibrosis
- London Centre for Nanotechnology
- London Genetics
- Lou Gehrig's disease
- Lumacan
- luminal progenitor cells
- Luminex
- lung cancer
- lung damage biomarker
- lung disease
- Lung Diseases
- lupus
- Lupus nephritis
- Lyme disease
- MabCure
- macroalbuminuria
- macrosomia
- magnetic resonance spectroscopy
- Mass spectrometry
- Massachusetts
- Max Planck Institute for Infection Biology
- Mayo Clinic
- McGill University
- MCI
- MD Anderson Cancer Center
- MDxHealth
- measles
- Medco
- MedStar Washington Hospital Center
- melanoma
- mental illness biomarkers
- Merck
- Merck KGaA
- mesothelioma
- metabolome
- metabolomic biomarker
- Metabolon
- METABRIC
- Metamark
- Metastasis
- Methodist Cancer Center
- Michael J. Fox Foundation
- microneedles
- micropatch
- microRNA
- microsponge
- mild cognitive impairment
- miRNA
- MIT
- mitochondria
- MK-8931
- Mount Sinai
- MSA
- Multiple myeloma
- multiple sclerosis
- myelin
- myocardial infarction
- myoglobin
- Myriad Genetics
- Nanomix
- nanoparticles
- NanoSponges
- NanoVelcro Chip
- National Cancer Institute
- National Health Service
- National Institutes of Health
- Nature Neurosciences
- NeoProteomics
- Neuroblastoma
- neuroendocrine cancers
- neurological disorders
- neurological signature
- neurons
- New England Journal of Medicine
- New York University
- NIH
- NMDA
- non-small cell lung cancer
- nonlipid biomarkers
- Northern Institute For Cancer Research
- Novartis
- Novo Nordisk
- Nuclea Biotechnologies
- nutrition biomarkers
- obesity
- ocular tremor
- oncology
- Onconova Therapeutics
- OncoSec
- oral cancer
- osteoarthritis
- osteoporosis
- Ovarian cancer
- ovarian cancer biomarker
- Oxford Gene Technology
- Pacific Biomarkers
- pain
- pain biomarker
- pancreatic cancer
- pancreatic secretions
- pancreatitis
- Parkinson's
- PARP inhibitor
- Pathwork Diagnostics
- Paul Broca
- PCA3 gene
- pediatric biomarkers
- peptoids
- periodontal disease
- peripheral artery disease
- personalized medicine
- PET imaging
- PET scan
- Pfizer
- Photocure
- PI3K
- PODXL
- polyps
- postpartum depression
- PPMI
- Predictive Biosciences
- preeclampsia
- pregnancy
- PrognosDx Health
- Promega
- prostate cancer
- prostate-specific antigen
- Protagen
- protein biomarker
- proteins
- Proteome Sciences
- Proteomics
- PSA
- psychological disorders
- PTSD
- pulmonary embolism
- Qiagen
- Quanterix
- Quartz Bio
- Quest Diagnostics
- quinolinic acid
- Quintiles
- radiation
- Randox Laboratories
- relapsing remitting MS
- Remicade
- renal cell carcinoma
- Renal Disease
- renin
- Repligen
- resveratrol
- RG3039
- rheumatoid arthritis
- Ridge Diagnostics
- river blindness
- Roche
- Rosetta Genomics
- Rules-Based Medicine
- safety biomarkers
- Salimetrics
- saliva biomarkers
- Salix Pharmaceuticals
- San Diego
- Sanofi
- sarcoidosis
- Saudi Arabia
- schizophrenia
- schizophrenia risk
- Science Translational Medicine
- sclerostin
- Scripps Research Institute
- Scripps Translational Science Institute
- SDC2
- Seaside Therapeutics
- Sengenics
- sepsis
- Sera Prognostics
- Serametrix
- serious adverse events
- serum samples
- Shanghai Biochip
- Siena Biotech
- Sirius Genomics
- skin conditions
- smoking cessation
- soluble (pro)renin receptor
- Southampton University
- spinal muscular atrophy
- spinostics
- Squamous Cell Carcinomas
- Stallergenes
- stem cells
- stomach cancer
- stress biomarkers
- stroke
- suicide
- SureGene
- systems biology
- T cells
- Takeda Pharmaceuticals
- tamoxifen
- tau protein
- teenagers
- telatinib
- telomeres
- Tethys Bioscience
- TFF
- The Lancet
- The New England Journal of Medicine
- The Queen Elizabeth Hospital Birmingham UK
- Thermo Fisher
- Thomas Jefferson University
- thyroid cancer
- tivozanib
- toxicity biomarkers
- Transgenomic
- traumatic brain injury
- triple-negative breast cancer
- tropical diseases
- troponin
- tuberculosis
- Tufts University School of Medicine
- type 1 diabetes
- type 2 diabetes
- Type I Diabetes
- U.K. Institute of Cancer Research
- UCSF
- ulcers
- United Kingdom
- University of Arizona
- University of California
- University of Cambridge
- University of Colorado
- University of Illinois
- University of Illinois Hospital & Health Sciences System
- University of Kentucky
- University of New South Wales
- University of Oklahoma
- University of Oxford
- uric acid
- urine
- urine test
- Van Andel Institute
- Vanderbilt-Ingram Cancer Center
- veliparib
- Verastem
- Vermillion
- Vertex
- VIPR1
- Viruses
- vitamin B6
- VKORC1
- VS-6063
- warfarin
- Washington University School of Medicine
- weight loss
- white blood cells
- whole genome sequencing
- Wilex
- Zinfandel Pharmaceuticals
THE LIBRARY: WEBINAR
IT challenges for the mobile health market
The mobile health market is moving rapidly, with apps now helping patients collect health data and physicians tapping into that data remotely. Join as we examine mobile health advances, patient privacy challenges, and how the FDA is evolving its thinking on regulating mobile apps. Register Today!
Latest Commentary
New biweekly email newsletter frequency
Biomarkers making a difference in clinical trials
Protein biomarkers: Here's a view from Sweden
Genetic biomarkers and the frets of the 'worried well'
Inform Genomics: Personalized medicine uses genetic markers with a twist
more
EVENTS
- BioClinica is Making DIA Fun! June 23-27 — Boston, MA
- BioImmersion Three-Day CourseJuly 10-12 — Chicago, IL
- BioBasics: Biotech for the Non-ScientistSeptember 16-17 — Boston, MA
Press Releases
- Rare genomic mutations found in 10 families with early-onset, familial Alzheimer's disease
- Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit
- Osteoporosis Drug Stops Growth of Breast Cancer Cells, Even in Resistant Tumors
- IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
- Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds
- More Press Releases
Featured Jobs
-
SENIOR PROJECT MANAGER - GLOBAL MEDICAL PUBLICATIONS - 130000024H
Abbvie - Chicago IL United States -
Associate Director, Drug Sample Management Job
Celgene Corporation - Basking Ridge NJ US -
Psychiatric Principal Investigator
Bushwick TMO - Brooklyn Ny USA -
Senior Director, Product Mktg II Job
Celgene Corporation - Warren Township NJ US -
Manufacturing Process Engineer
Bristol-Myers Squibb -
